Alicia Zhou, PhD, became CRI’s president effective August 26, and succeeded Jill O’Donnell-Tormey, PhD, who had led the Institute since 1993.

Increase in the prevalence of chronic disorders, rise in government support, and ethical acceptance of gene therapy for cancer treatment drive the growth. David Correa Allied Market Research +1 ...

CRISPR technology allows for precise DNA modifications, holding promise for treating genetic disorders and revolutionizing ...

As part of the CURE® Educated Patient® Prostate Cancer Summit, an expert discussed the role genetic testing plays in ...

In March 2023, the Organising Committee of the Third International Summit on Human Genome Editing published a statement ...

Gene Park is a reporter for The Washington Post, covering video games and gaming culture. He joined The Post in 2015 as audience editor, and is a former reporter in the West Coast and Pacific region.

Feasibility and Clinical Utility of Reporting Hereditary Cancer Predisposition Pathogenic Variants Identified in Research Germline Sequencing: A Prospective Interventional Study ACP1-High tumors ...

BOSTON - Boston is home to a National STEM Champion, an eleventh-grader whose project revolved around gene therapy. A student at Boston Latin School, Evan Ding may look like your average high ...

Her Royal Highness, The Princess Royal, officially opened the Gene Therapy Innovation and Manufacturing Centre (GTIMC) at the University of Sheffield today (2 October 2024). New Gene Therapy ...

The affected child does not carry the P variant. B. Hypothesis 2: a damaging variant (D) is present in the germline of the parent who does not carry TP53 p.R337H and is absent in the carrier parent.

In particular, mutations in the PDGFRB gene lead to constitutively activated ERK and nuclear factor κB signaling ... Hereditary IAs account for only 10% of all IA cases and therefore attention has ...

Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma Using pooled ...